Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma

Increasing cure rates of solid tumors by immune checkpoint inhibitors, Experimental Hematology & Oncology

Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

Neoadjuvant-Adjuvant Pembrolizumab Better Than Adjuvant-Only in Melanoma

Comparison of neoadjuvant and adjuvant immunotherapies. Neoadjuvant

Cancers, Free Full-Text

Adjuvant and Neoadjuvant Therapy in Melanoma - Rodabe N. Amaria, MD

Neoadjuvant or adjuvant immunotherapy in melanoma stage iii

Neoadjuvant immunotherapy improves outlook in

Emerging precision neoadjuvant systemic therapy for patients with resectable non-small cell lung cancer: current status and perspectives, Biomarker Research

Immune Checkpoint Inhibitor Therapy in Oncology: Current Uses and Future Directions: JACC: CardioOncology State-of-the-Art Review - ScienceDirect

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma